The predictive accuracy of staging transurethral resection of the prostate in the management of stage A cancer of the prostate: A comparative evaluation

B. A. Lowe, John Barry

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The role of staging transurethral resection of the prostate in the management of stage A prostate cancer is controversial. The accuracy of staging transurethral resection, A1/A2 substaging and probability of progression tables for predicting cancer progression was evaluated in untreated patients with stage A adenocarcinoma of the prostate who were followed for at least 5 years. Survival free of disease was predicted correctly in 93% of 52 patients who underwent staging transurethral resection of the prostate, 92% of 96 with the probability tables and in 85% of 96 using a common criteria for A1 and A2 substaging. Staging transurethral resection of the prostate upgraded patient risk in 7% of the low risk patients predicted by the probability tables and 14% of the stage A1 cancer patients. Staging transurethral prostatectomy and the probability of progression tables were more accurate in predicting survival free of disease than the A1/A2 substaging system. Comparison of the predictive accuracy of staging transurethral prostatectomy to that of the probability of progression tables showed no significant difference. There was no additional benefit from combining the 2 methods. When the probability of progression tables are used to predict cancer progression it may be unnecessary to use staging transurethral resection of the prostate in the patient with stage A prostate cancer.

Original languageEnglish (US)
Pages (from-to)1142-1145
Number of pages4
JournalJournal of Urology
Volume143
Issue number6
StatePublished - 1990

Fingerprint

Transurethral Resection of Prostate
Prostatic Neoplasms
varespladib methyl
Disease-Free Survival
Neoplasms
Prostate
Adenocarcinoma

ASJC Scopus subject areas

  • Urology

Cite this

@article{606d972f52d34412b05c1541c9dd0dd7,
title = "The predictive accuracy of staging transurethral resection of the prostate in the management of stage A cancer of the prostate: A comparative evaluation",
abstract = "The role of staging transurethral resection of the prostate in the management of stage A prostate cancer is controversial. The accuracy of staging transurethral resection, A1/A2 substaging and probability of progression tables for predicting cancer progression was evaluated in untreated patients with stage A adenocarcinoma of the prostate who were followed for at least 5 years. Survival free of disease was predicted correctly in 93{\%} of 52 patients who underwent staging transurethral resection of the prostate, 92{\%} of 96 with the probability tables and in 85{\%} of 96 using a common criteria for A1 and A2 substaging. Staging transurethral resection of the prostate upgraded patient risk in 7{\%} of the low risk patients predicted by the probability tables and 14{\%} of the stage A1 cancer patients. Staging transurethral prostatectomy and the probability of progression tables were more accurate in predicting survival free of disease than the A1/A2 substaging system. Comparison of the predictive accuracy of staging transurethral prostatectomy to that of the probability of progression tables showed no significant difference. There was no additional benefit from combining the 2 methods. When the probability of progression tables are used to predict cancer progression it may be unnecessary to use staging transurethral resection of the prostate in the patient with stage A prostate cancer.",
author = "Lowe, {B. A.} and John Barry",
year = "1990",
language = "English (US)",
volume = "143",
pages = "1142--1145",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - The predictive accuracy of staging transurethral resection of the prostate in the management of stage A cancer of the prostate

T2 - A comparative evaluation

AU - Lowe, B. A.

AU - Barry, John

PY - 1990

Y1 - 1990

N2 - The role of staging transurethral resection of the prostate in the management of stage A prostate cancer is controversial. The accuracy of staging transurethral resection, A1/A2 substaging and probability of progression tables for predicting cancer progression was evaluated in untreated patients with stage A adenocarcinoma of the prostate who were followed for at least 5 years. Survival free of disease was predicted correctly in 93% of 52 patients who underwent staging transurethral resection of the prostate, 92% of 96 with the probability tables and in 85% of 96 using a common criteria for A1 and A2 substaging. Staging transurethral resection of the prostate upgraded patient risk in 7% of the low risk patients predicted by the probability tables and 14% of the stage A1 cancer patients. Staging transurethral prostatectomy and the probability of progression tables were more accurate in predicting survival free of disease than the A1/A2 substaging system. Comparison of the predictive accuracy of staging transurethral prostatectomy to that of the probability of progression tables showed no significant difference. There was no additional benefit from combining the 2 methods. When the probability of progression tables are used to predict cancer progression it may be unnecessary to use staging transurethral resection of the prostate in the patient with stage A prostate cancer.

AB - The role of staging transurethral resection of the prostate in the management of stage A prostate cancer is controversial. The accuracy of staging transurethral resection, A1/A2 substaging and probability of progression tables for predicting cancer progression was evaluated in untreated patients with stage A adenocarcinoma of the prostate who were followed for at least 5 years. Survival free of disease was predicted correctly in 93% of 52 patients who underwent staging transurethral resection of the prostate, 92% of 96 with the probability tables and in 85% of 96 using a common criteria for A1 and A2 substaging. Staging transurethral resection of the prostate upgraded patient risk in 7% of the low risk patients predicted by the probability tables and 14% of the stage A1 cancer patients. Staging transurethral prostatectomy and the probability of progression tables were more accurate in predicting survival free of disease than the A1/A2 substaging system. Comparison of the predictive accuracy of staging transurethral prostatectomy to that of the probability of progression tables showed no significant difference. There was no additional benefit from combining the 2 methods. When the probability of progression tables are used to predict cancer progression it may be unnecessary to use staging transurethral resection of the prostate in the patient with stage A prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=0025293607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025293607&partnerID=8YFLogxK

M3 - Article

C2 - 2342175

AN - SCOPUS:0025293607

VL - 143

SP - 1142

EP - 1145

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 6

ER -